From GNBT Twitter: “With the launch of our su
Post# of 36519
![](/assets/46931549/no_avatar_available_thumb.jpg)
“With the launch of our subsidiary's new website, nugenerexio.com, we have dedicated a large portion of the site to further explain how our Ii-key #vaccine technology platform is applied in cancer and infectious diseases like triple-negative breast cancer and #COVID19.”
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)